Aaron Schwartz, D.O. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 8890 W Oakland Park Blvd, Ste 100, Sunrise, FL 33351 Phone: 954-749-7117 Fax: 954-741-3306 |
Dr. Kumar Rajagopalan, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3505 Nw 84th Ave, Sunrise, FL 33351 Phone: 954-906-0204 Fax: 954-289-3902 |
News Archive
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the diabetes, cancer, dermatology and drug delivery markets, today announced the commencement of a Phase 1/2 clinical trial with HTI-501 (rHuCAT-L) in women with moderate to severe edematous fibrosclerotic panniculopathy (also known as cellulite).
Infection preventionists and healthcare epidemiologists play key roles in promoting effective antimicrobial stewardship in collaboration with other health professionals, according to a joint position paper published today by the Association for Professionals in Infection Control and Epidemiology (APIC) and the Society for Healthcare Epidemiology of America (SHEA) in their respective peer-review journals, the American Journal of Infection Control and Infection Control and Hospital Epidemiology.
Intellect Neurosciences, Inc., a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for the treatment and prevention of Alzheimer's disease, today announced that it is pleased with the recent press coverage the Company and Dr. Daniel G. Chain, Ph.D., the Company's Chairman and Chief Executive Officer, recently has received.
Patient Safety Technologies, Inc. announced today the closing of a $6.0 million private placement financing. The new capital will primarily be used to fund working capital and the continued growth of the Company.
› Verified 8 days ago